Clinical Trial Update: Intravitreal Bevacizumab for Neovascular Glaucoma [NA]

View source ↗

Summary

This clinical trial update indicates that the study evaluating intravitreal bevacizumab for neovascular glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Glaucoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Neovascular, Glaucoma | NA | Status: COMPLETED